Skip to main content


Analyst & Investor Day

Emergent BioSolutions hosted an Analyst & Investor Day last December 7, 2017.

Thursday, December 7
8:00 a.m. - 12:30 p.m. EST
New York City

CEO Vision and Strategy
US Government Perspective on Public Health Threats
US/ROW Market Overview
Business Unit Overview
R&D Pipeline Overview
External Funding Overview
Corporate Development
Financial Update

With Q&A throughout the event.


  • Dan Abdun-Nabi, President & CEO
  • Bob Kramer, EVP & CFO
  • Adam Havey, EVP
  • Doug White, EVP
  • Laura Saward, Ph.D., SVP
  • Sean Kirk, SVP
  • Darren Buchwald, SVP
  • Jim Jackson, Ph.D., SVP & CSO
  • Barb Solow, SVP
  • Atul Saran, EVP & CLO
  • Chris Frech, SVP
  • And,

  • Honorable Mike Rogers, U.S. House of Representatives (Michigan) (Retired)

Learn more about speakers bios here.




Event Transcript

Analyst & Investor Day 2017 Presentation

Supplemental Materials

A National Blueprint for Biodefense

CBRNE Threat Landscape

EU Commission Report on CBRNE Risks

PHEMCE Strategy and Implementation Plan